Leading biotech incubator Flagship Pioneering has announced its latest investment, with the launch of a viral proteome start-up, Prologue Medicines. 8 May 2024
Three of the world’s largest public health organizations are to join forces, backing a new research and development initiative with $300 million in funding. 7 May 2024
California-based biopharma BridgeBio Pharma (Nasdaq: BBIO) has announced the completion of a $200 million private financing of its former subsidiary, TheRas. 3 May 2024
Californian firm Daré Bioscience has completed a royalty monetization deal with XOMA (Nasdaq: XOMA), a company providing an alternative mechanism for biotechs t 2 May 2024
Californian biotech Enlaza Therapeutics has raised $100 million in a series A financing led by J.P. Morgan Asset Management’s Private Capital division. 1 May 2024
Swedish Orphan Biovitrum, a rare disease company also known as Sobi, is set to raise around 10 billion Swedish kroner ($920 million) in debt. 26 April 2024
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid on the part of Sun Pharmaceutical. 24 April 2024
In San Francisco, a new company focused on using artificial intelligence to power drug discovery has launched with more than $1 billion of committed capital. 24 April 2024
Connecticut, USA-based biotech company Biohaven has priced an underwritten public offering with the goal of raising approximately $230 million. 19 April 2024
British oncology start-up Pathios Therapeutics has raised $25 million in the first close of a series B financing, including a new strategic investment from Bris 19 April 2024
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.